Cover Image

Design, Synthesis, and Evaluation of Benzoheterocyclic-Containing Derivatives as Novel HDAC1 Inhibitors

Abstract In this study, the synthesis and biological evaluation of a variety of benzoheterocyclic-containing benzamide derivatives were described. Some of these compounds were proved to inhibiting the activity of histone deacetylase 1 (HDAC1) with IC50 values below the micromolar range, retarding pr...

Full description

Saved in:

Bibliographic Details
Main Authors:	Min-Ru Jiao (Author), Bo Han (Author), Xiu Gu (Author), Hao Zhang (Author), Ai-Ping Wang (Author), Qing-Wei Zhang (Author)
Format:	Book
Published:	Georg Thieme Verlag KG, 2022-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Discovery of Indole-Containing Benzamide Derivatives as HDAC1 Inhibitors with In Vitro and In Vivo Antitumor Activities
by: Xiu Gu, et al.
Published: (2022)

Design, synthesis, and biological evaluation of benzoheterocyclic sulfoxide derivatives as quorum sensing inhibitors in Pseudomonas aeruginosa
by: Shen Mao, et al.
Published: (2023)

Design, Synthesis, and Biological Evaluation of 2-Anilino-4-Triazolpyrimidine Derivatives as CDK4/HDACs Inhibitors
by: Wang S, et al.
Published: (2022)

Design, Synthesis, and Biological Evaluation of Dual c-Met/HDAC Inhibitors Bearing 2-Aminopyrimidine Scaffold
by: Qingwei Zhang, et al.
Published: (2020)

Design, Synthesis, and Biological Evaluation of Dual c-Met/HDAC Inhibitors Bearing 2-Aminopyrimidine Scaffold
by: Qingwei Zhang, et al.
Published: (2020)

Design, synthesis and biological evaluation of 2,4-pyrimidinediamine derivatives as ALK and HDACs dual inhibitors for the treatment of ALK addicted cancer
by: Dafeng Guo, et al.
Published: (2022)

Phosphorus containing analogues of SAHA as inhibitors of HDACs
by: Michael D. Pun, et al.
Published: (2022)

Design and synthesis of triazolopyridine derivatives as potent JAK/HDAC dual inhibitors with broad-spectrum antiproliferative activity
by: Zhengshui Xu, et al.
Published: (2024)

Design, synthesis and biological evaluation of novel histone deacetylase (HDAC) inhibitors derived from β-elemene scaffold
by: Yuan Gao, et al.
Published: (2023)

N-Myristoyltransferases as antileishmanial targets: a piggyback approach with benzoheterocyclic analogues
by: Luis Otávio Junqueira, et al.
Published: (2019)

Design, Synthesis and Biological Evaluation of New HDAC1 and HDAC2 Inhibitors Endowed with Ligustrazine as a Novel Cap Moiety
by: Al-Sanea MM, et al.
Published: (2020)

Design, synthesis and evaluation of quinolinone derivatives containing dithiocarbamate moiety as multifunctional AChE inhibitors for the treatment of Alzheimer's disease
by: Jie Fu, et al.
Published: (2020)

An Improved Synthesis Process of Ricolinostat: The First Orally Selective HDAC6 Inhibitor
by: Mengfei Wang, et al.

Discovery of New Uracil and Thiouracil Derivatives as Potential HDAC Inhibitors
by: Omnia R. Elbatrawy, et al.
Published: (2023)

HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis
by: Xing Lyu, et al.
Published: (2019)

Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin-HDAC Inhibitor Hybrids as Multitarget Drugs
by: Lukas von Bredow, et al.
Published: (2022)

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
by: Elizabeth A. Thomas
Published: (2014)

Design, Synthesis, In Vitro Anticancer Evaluation and Molecular Modelling Studies of 3,4,5-Trimethoxyphenyl-Based Derivatives as Dual EGFR/HDAC Hybrid Inhibitors
by: Tarek S. Ibrahim, et al.
Published: (2021)

Optimization of Resveratrol Used as a Scaffold to Design Histone Deacetylase (HDAC-1 and HDAC-2) Inhibitors
by: Beatriz Silva Urias, et al.
Published: (2022)

The efficacy of HDAC inhibitors in neoplasm treatment
by: Dominika Psiuk, et al.
Published: (2020)

Nanomaterials as potential transporters of HDAC inhibitors
by: Cristabelle De Souza, et al.
Published: (2020)

Asymmetric Synthesis of 1,2-Limonene Epoxides by Jacobsen Epoxidation
by: Zi-Yi Huang, et al.
Published: (2021)

Synergistic antitumor activity of artesunate and HDAC inhibitors through elevating heme synthesis via synergistic upregulation of ALAS1 expression
by: Cai-Ping Chen, et al.
Published: (2019)

Effects of structurally distinct human HDAC6 and HDAC6/HDAC8 inhibitors against S. mansoni larval and adult worm stages.
by: Roberto Gimmelli, et al.
Published: (2024)

Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors
by: María Galán, et al.
Published: (2016)

Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis
by: Ehab Ghazy, et al.
Published: (2022)

Design, synthesis and antitumor activity of 5-trifluoromethylpyrimidine derivatives as EGFR inhibitors
by: Yaqing Zuo, et al.
Published: (2022)

Discovery of SIPI6473, a New, Potent, and Orally Bioavailable Multikinase Inhibitor for the Treatment of Non-small Cell Lung Cancer
by: Xiu Gu, et al.
Published: (2021)

Design, synthesis and biological evaluation of novel diarylpyridine derivatives as tubulin polymerisation inhibitors
by: Shanbo Yang, et al.
Published: (2022)

Molecular design, synthesis and in vitro biological evaluation of thienopyrimidine-hydroxamic acids as chimeric kinase HDAC inhibitors: a challenging approach to combat cancer
by: Mona M. Abdel-Atty, et al.
Published: (2021)

Novel Single Inhibitor of HDAC6/8 and Dual Inhibitor of PI3K/HDAC6 as Potential Alternative Treatments for Prostate Cancer
by: Fabiana Sélos Guerra, et al.
Published: (2021)

The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs.
by: Hugo Rolando Vaca, et al.
Published: (2021)

Opportunities and Difficulties in the Repurposing of HDAC Inhibitors as Antiparasitic Agents
by: Tapas Kumar Mohapatra, et al.
Published: (2024)

HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer
by: Cristina Maccallini, et al.
Published: (2022)

Synthesis and Crystal Structure Analysis of Histone Deacetylase Inhibitor Chidamide
by: Bo Han, et al.
Published: (2023)

HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
by: Nan Liu, et al.
Published: (2022)

HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
by: Nan Liu, et al.
Published: (2022)

A Review on Molecular Docking on HDAC Isoforms: Novel Tool for Designing Selective Inhibitors
by: Aliki Drakontaeidi, et al.
Published: (2023)

Novel HDAC/Tubulin Dual Inhibitor: Design, Synthesis and Docking Studies of α-Phthalimido-Chalcone Hybrids as Potential Anticancer Agents with Apoptosis-Inducing Activity
by: Mourad AAE, et al.
Published: (2020)

Design, synthesis, and antifungal activities of novel triazole derivatives containing the benzyl group
by: Xu K, et al.
Published: (2015)